cAMP Responsive Element Binding Protein-1 Is a Transcription Factor of Lysosomal-Associated Protein Transmembrane-4 beta in Human Breast Cancer Cells

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Zhang, Meng ^a   Xu, Jian Jun ^a   Zhou, Rou Li ^b   Zhang, Qing Yun ^a  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 2; LUCIFERASE; MESSENGER RNA;

ARTICLE; BINDING SITE; BREAST CANCER; CANCER CELL CULTURE; CONTROLLED STUDY; EXON; GEL MOBILITY SHIFT ASSAY; GENE; GENE AMPLIFICATION; HUMAN; HUMAN CELL; LYSOSOMAL ASSOCIATED PROTEIN TRANSMEMBRANE 4 BETA GENE; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTEIN BINDING; PROTEIN FUNCTION; RNA INTERFERENCE; TRANSCRIPTION REGULATION;

BASE SEQUENCE; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE, TUMOR; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DNA PRIMERS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FEMALE; GENE KNOCKDOWN TECHNIQUES; HUMANS; LYSOSOME-ASSOCIATED MEMBRANE GLYCOPROTEINS; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS;

EID: 84874569495     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057520     Document Type: Article

References (32)

1. Milkereit R, Rotin D, (2011) A role for the ubiquitin ligase Nedd4 in membrane sorting of LAPTM4 proteins. PLoS One 6: e27478.
2. Kasper G, Vogel A, Klaman I, Grone J, Petersen I, et al. (2005) The human LAPTM4b transcript is up-regulated in various types of solid tumours and seems to play a dual functional role during tumour progression. Cancer Lett 224: 93-103.
3. Yang H, Lin M, Xiong FX, Yang Y, Nie X, et al. (2011) Combined lysosomal protein transmembrane 4 beta-35 and argininosuccinate synthetase expression predicts clinical outcome in hepatocellular carcinoma patients. Surg Today 41: 810-817.
4. Yang H, Xiong FX, Qi R, Liu Z, Lin M, et al. (2010) LAPTM4B-35 is a novel prognostic factor of hepatocellular carcinoma. J Surg Oncol 101: 363-369.
5. Peng C, Zhou RL, Shao GZ, Rui JA, Wang SB, et al. (2005) Expression of lysosome-associated protein transmembrane 4B-35 in cancer and its correlation with the differentiation status of hepatocellular carcinoma. World J Gastroenterol 11: 2704-2708.
6. Zhou L, He XD, Yu JC, Zhou RL, Shan Y, et al. (2011) Overexpression of LAPTM4B-35 attenuates epirubucin-induced apoptosis of gallbladder carcinoma GBC-SD cells. Surgery 150: 25-31.
7. Zhou L, He XD, Chen J, Cui QC, Qu Q, et al. (2007) Overexpression of LAPTM4B-35 closely correlated with clinicopathological features and post-resectional survival of gallbladder carcinoma. Eur J Cancer 43: 809-815.
8. Kang Y, Yin MZ, Jiang W, Zhang H, Xia B, et al. (2012) Overexpression of LAPTM4B-35 is associated with poor prognosis in colorectal carcinoma. Am J Surg.
9. Yin MZ, Li C, Li X, Lou G, Miao B, et al. (2011) Over-expression of LAPTM4B is associated with poor prognosis and chemotherapy resistance in stages III and IV epithelial ovarian cancer. J Surg Oncol 104: 29-36.
10. Meng FL, Yin MZ, Song HT, Yang H, Lou G, et al. (2010) LAPTM4B-35 overexpression is an independent prognostic marker in endometrial carcinoma. Int J Gynecol Cancer 20: 745-750.
11. Li L, Wei XH, Pan YP, Li HC, Yang H, et al. (2010) LAPTM4B: a novel cancer-associated gene motivates multidrug resistance through efflux and activating PI3K/AKT signaling. Oncogene 29: 5785-5795.
12. Li Y, Zou L, Li Q, Haibe-Kains B, Tian R, et al. (2010) Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer. Nat Med 16: 214-218.
13. Shao GZ, Zhou RL, Zhang QY, Zhang Y, Liu JJ, et al. (2003) Molecular cloning and characterization of LAPTM4B, a novel gene up-regulated in hepatocellular carcinoma. Oncogene 22: 5060-5069.
14. Mayr B, Montminy M, (2001) Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol 2: 599-609.
15. Sakamoto KM, Frank DA, (2009) CREB in the pathophysiology of cancer: implications for targeting transcription factors for cancer therapy. Clin Cancer Res 15: 2583-2587.
16. Euskirchen G, Royce TE, Bertone P, Martone R, Rinn JL, et al. (2004) CREB binds to multiple loci on human chromosome 22. Mol Cell Biol 24: 3804-3814.
17. Fusco S, Ripoli C, Podda MV, Ranieri SC, Leone L, et al. (2012) A role for neuronal cAMP responsive-element binding (CREB)-1 in brain responses to calorie restriction. Proc Natl Acad Sci U S A 109: 621-626.
18. Liang Z, Liu F, Grundke-Iqbal I, Iqbal K, Gong CX, (2007) Down-regulation of cAMP-dependent protein kinase by over-activated calpain in Alzheimer disease brain. J Neurochem 103: 2462-2470.
19. Kinjo K, Sandoval S, Sakamoto KM, Shankar DB, (2005) The role of CREB as a proto-oncogene in hematopoiesis. Cell Cycle 4: 1134-1135.
20. Hsieh TH, Tsai CF, Hsu CY, Kuo PL, Lee JN, et al. (2012) Phthalates induce proliferation and invasiveness of estrogen receptor-negative breast cancer through the AhR/HDAC6/c-Myc signaling pathway. FASEB J 26: 778-787.
21. Naderi A, Meyer M, Dowhan DH, (2012) Cross-regulation between FOXA1 and ErbB2 Signaling in Estrogen Receptor-Negative Breast Cancer. Neoplasia 14: 283-296.
22. Lonze BE, Ginty DD, (2002) Function and regulation of CREB family transcription factors in the nervous system. Neuron 35: 605-623.
23. San-Marina S, Han Y, Liu J, Minden MD, (2012) Suspected leukemia oncoproteins CREB1 and LYL1 regulate Op18/STMN1 expression. Biochim Biophys Acta 1819: 1164-1172.
24. Naderi A, Meyer M, Dowhan DH, (2012) Cross-regulation between FOXA1 and ErbB2 signaling in estrogen receptor-negative breast cancer. Neoplasia 14: 283-296.
25. Wiggin GR, Soloaga A, Foster JM, Murray-Tait V, Cohen P, et al. (2002) MSK1 and MSK2 are required for the mitogen- and stress-induced phosphorylation of CREB and ATF1 in fibroblasts. Mol Cell Biol 22: 2871-2881.
26. Naviglio S, Di Gesto D, Illiano F, Chiosi E, Giordano A, et al. (2010) Leptin potentiates antiproliferative action of cAMP elevation via protein kinase A down-regulation in breast cancer cells. J Cell Physiol 225: 801-809.
27. Hsieh TH, Tsai CF, Hsu CY, Kuo PL, Lee JN, et al. (2012) Phthalates induce proliferation and invasiveness of estrogen receptor-negative breast cancer through the AhR/HDAC6/c-Myc signaling pathway. FASEB J 26: 778-787.
28. Makhov P, Golovine K, Uzzo RG, Wuestefeld T, Scoll BJ, et al. (2009) Transcriptional regulation of the major zinc uptake protein hZip1 in prostate cancer cells. Gene 431: 39-46.
29. Deng L, Li Y, Huang JM, Zhou G, Qian W, et al. (2011) Effects of p-CREB-1 on transforming growth factor-beta3 auto-regulation in hepatic stellate cells. J Cell Biochem 112: 1046-1054.
30. Kim CH, Xiong WC, Mei L, (2005) Inhibition of MuSK expression by CREB interacting with a CRE-like element and MyoD. Mol Cell Biol 25: 5329-5338.
31. Zhou Q, Gedrich RW, Engel DA, (1995) Transcriptional repression of the c-fos gene by YY1 is mediated by a direct interaction with ATF/CREB. J Virol 69: 4323-4330.
32. San-Marina S, Han Y, Liu J, Minden MD, (2012) Suspected leukemia oncoproteins CREB1 and LYL1 regulate Op18/STMN1 expression. Biochim Biophys Acta 1819: 1164-1172.